Skip to content

Evaluation of Stool Microbiome Using HyGIeaCare Prep

Pilot Study: Quality Evaluation of Stool Samples Collected for Microbiome Analysis Using the HyGIeaCare Prep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04264923
Enrollment
14
Registered
2020-02-11
Start date
2019-06-27
Completion date
2020-06-30
Last updated
2020-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stool Microbiome

Brief summary

Stool samples will be collected before and during the HyGIeaCare procedure and the samples will be sent for microbiome evaluation.

Detailed description

Patients will have the HyGIeaCare procedure as originally prescribed by their physician. Before and during the procedure stool samples will be collected and sent to a lab for microbiome evaluation. It is anticipated that stool samples collected from the HyGIeaCare prep will provide more microbiological and biochemical information on the gut interior than using traditional stool samples.

Interventions

Each patient will have up to 5 stool specimens for evaluation by a lab for microbial contents.

Sponsors

HyGIeaCare, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Patients between 18 and 80 years old who do not have any known health issues and who have not taken antibiotics within the last two months.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient's age is between 18 and 80 years old scheduled for elective screening or polyp surveillance indicated colonoscopy 2. Patient does not have any known health issues (as listed in

Exclusion criteria

) 3. Patient had not taken antibiotics within the last 2 months

Design outcomes

Primary

MeasureTime frameDescription
Microbial classification6 monthsThe number of genes present will be counted
Diversity between stool and colon effluent samples6 monthsAlpha diversity by Shannon diversity index, presence and number of taxa to be documented
Inner diversity of samples6 monthsANOVA test will be used to acknowledge differences between samples, presence and number of taxa to be documented
Contribution of the variables to samples' diversity6 monthsPrincipal component analysis (PCoA) will be used to mark significant differences between the samples, taxa will be identified by presence, percentage of sample will be documented

Secondary

MeasureTime frameDescription
Functional genes analysis6 monthsThe presence of genes known to represent biochemical functions will be counted and documented
Biosynthetic gene clusters6 monthsGroups of genes with known biosynthetic functions and found to be clustered will be counted and documented together in the different samples

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026